Meet the Author: Dr. Daniela Esposito (@DanielaEspo89), a Postdoc from @UninaIT, is 1st author of “Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma,” recently published in #JITC! 1/6
Drs. Roberto Bianco & Luigi Formisano's team at @UninaIT proposes that Pak1 inhibitors combined with #EndocrineTherapy and CDK4/6 inhibitors can be a possible approach for the treatment of ER+ resistant #BreastCancers.
🔎 Find out more about the study: https://t.co/fIT0O8rckl
📣 Excited to share our last work on the role of PAK1 as mechanism of resistance to cdk4/6 inhibitors in er+/her2- breast cancer
https://t.co/jIO8k6e4Lh
#Jobopportunity#postdoctoralfellowship
We are looking for a PostDoctoral Fellow to join the lab of Molecular Cancer Therapy at University of Naples Federico II.
This position will be funded by My First #AIRC Grant (MFAG).
⬇️⬇️⬇️
https://t.co/5XM8wamXWG